Remove Bioavailability Remove Genotype Remove In-Vivo Remove Vaccination
article thumbnail

Innovative Companies Diving into The Neuro Market Ahead of 2021

The Pharma Data

With the expected Emergency Use Authorization (EUA) of Pfizer – BioNTech and Moderna ’s COVID-19 vaccines providing hope that the COVID-19 pandemic will soon be resolved, 2021 is going to need a new primary healthcare campaign. Could it come from the field of neuroscience? which will remain a key shareholder. SciNeuro Pharmaceuticals.